Company profile
DBV Technologies S.A. insider acquisitions
Company CIK 0001613780 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 22, 2026.
No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
7 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Nov 21, 2025 | DBV Technologies S.A.Employee Stock Option (right to buy) | Mohideen Pharis | Stock award |
| Nov 21, 2025 | DBV Technologies S.A.Ordinary Shares | Mohideen Pharis | Stock award |
| Nov 21, 2025 | DBV Technologies S.A.Employee Stock Option (right to buy) | Trapp Kevin Michael | Stock award |
| Nov 21, 2025 | DBV Technologies S.A.Ordinary Shares | Trapp Kevin Michael | Stock award |
| Nov 21, 2025 | DBV Technologies S.A.Employee Stock Option (right to buy) | Boucinha Virginie | Stock award |
| Nov 21, 2025 | DBV Technologies S.A.Ordinary Shares | Boucinha Virginie | Stock award |
| Nov 21, 2025 | DBV Technologies S.A.Employee Stock Option (right to buy) | Tasse Daniel | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
DBVT · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Mohideen PharisChief Medical Officer | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 253,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Mohideen PharisChief Medical Officer | Stock awardOrdinary SharesNon-derivative security · Code A | 44,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Trapp Kevin MichaelChief Commercial Officer | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 316,250 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Trapp Kevin MichaelChief Commercial Officer | Stock awardOrdinary SharesNon-derivative security · Code A | 55,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Boucinha VirginieChief Financial Officer | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 192,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Boucinha VirginieChief Financial Officer | Stock awardOrdinary SharesNon-derivative security · Code A | 32,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Tasse DanielCHIEF EXECUTIVE OFFICER · Director | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 964,000 | 0Value: 0Currency not specified | View ↗ |
7 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →